The artificial pancreas (AP) is equipped with a glucose monitoring sensor, an insulin pump
and an integrated mathematical algorithm that determines insulin infusion based on the …

OBJECTIVE The rapid insulin-alone artificial pancreas improves glycemia in type 1 diabetes
but daytime control remains suboptimal. We propose two novel dual-hormone artificial …

Over the last few years, technological advances have led to tremendous improvement in the
management of type 1 diabetes (T1D). Artificial pancreas systems have been shown to …

Objectives A fully automated insulin-pramlintide-glucagon artificial pancreas that alleviates
the burden of carbohydrate counting without degrading glycemic control was iteratively …

IN BRIEF Artificial pancreas systems are rapidly developing and constitute the most
promising technology for insulin-requiring diabetes management. Single-hormone systems …

The artificial pancreas—a promising approach for the treatment of type 1 diabetes mellitus
(T1DM)—has demonstrated superiority over conventional insulin pump therapy in clinical …

Aim Carbohydrate-counting is a complex task for many patients with type 1 diabetes. This
study examined whether an artificial pancreas, delivering insulin and glucagon based on …

In this issue of Diabetes Technology & Therapeutics, Wang et al. 1 evaluated a promising
novel fluorescencebased long-term implantable glucose sensor, underlining the potential of …

Aim To evaluate the efficacy and safety of a dual‐hormone artificial pancreas (DH) in type 1
diabetes. Material and Methods PubMed, Embase, the Cochrane Library and ClinicalTrials …

Background The artificial pancreas is an emerging technology for the treatment of type 1
diabetes and two configurations have been proposed: single-hormone (insulin alone) and …